GODAVARI DRUGS LIMITED

Meeting Details

  • Meeting Date: Friday, August 24, 2026
  • Primary Agenda: To consider and approve the Un-Audited Financial Results for the 1st quarter ended 30th June, 2026 along with Limited review report
  • Additional Agenda: Any other business with the permission of Chair

Trading Window Closure

Pursuant to the Company's Code of Conduct for Regulating, Monitoring and Reporting of Trading by Insiders and as previously intimated via letter dated 23rd June, 2026:

  • Trading Window Closure Period: From 1st July, 2026
  • Trading Window Reopening: 48 hours after declaration of Un-Audited Financial Results for the quarter ended 30th June, 2026